However, DGAT1/2 inhibitors aggravated ferroptosis resistance in the high-risk CCA cell lines, suggesting a role for lipid droplets as potential drivers of ferroptosis in CCA. The gene discussed is DGAT1; the disease is cholangiocarcinoma.